![Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter - ScienceDirect Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332218301173-fx1.jpg)
Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter - ScienceDirect
![DZIF-project-derived start-up “EBViously“ announces first details of its EBV vaccine candidate | German Center for Infection Research DZIF-project-derived start-up “EBViously“ announces first details of its EBV vaccine candidate | German Center for Infection Research](https://www.dzif.de/system/files/styles/dzif_teaser_tile_33_dzif_xl_1x/private/image/SARS-CoV-2%20NIAID7.jpg?h=aa65f56b&itok=76qOlsRl)
DZIF-project-derived start-up “EBViously“ announces first details of its EBV vaccine candidate | German Center for Infection Research
![Chronic Active Epstein-Barr Virus Infection disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials Chronic Active Epstein-Barr Virus Infection disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials](http://malacards.blob.core.windows.net/network-images-v5-15-2/chronic_active_epstein_barr_virus_infection_related_diseases.jpg)